Daraxonrasib Offers New Hope for Pancreatic Cancer

A breakthrough pill called daraxonrasib is reshaping the fight against advanced pancreatic cancer, nearly doubling survival time for patients who’ve stopped responding to chemo—and doing so with fewer side effects and improved quality of life. Targeting a once “undruggable” mutated protein, the drug works like molecular glue to halt tumor growth, offering hope where none existed before. Doctors are emotional, patients are thriving, and experts are calling it a potential new standard of care—with even broader applications on the horizon. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/48a86b5b2e51b155